This press release was updated on July 28, 2022 to reflect that Cleerly secured additional Series C funding, raising its round total from $192 million to $223 million. Updated July 28, 2022: New York – July 25, 2022 — Cleerly, the company creating a new standard of care for heart disease, announced […]
Other News
IRRAS AB publishes Interim Report for the period January to June 2022
STOCKHOLM, July 22, 2022 /PRNewswire/ — Continued progress during Q2 2022 ” The second quarter of 2022 provided the latest data point to confirm IRRAS’ progress toward becoming a leader in neurocritical care. Q2 represented the 8th consecutive quarter of revenue growth for our company, and our revenue of MSEK 9.7 (5.1) […]
Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
MORRISVILLE, N.C., July 21, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced that, in connection with the previously announced appointment of Rajeev Saggar, M.D., Liquidia’s new Chief Medical Officer, it has agreed to grant him an employment inducement equity award. As previously disclosed in a Current Report on […]
IRHYTHM GAINS FDA CLEARANCE FOR ITS CLINICALLY INTEGRATED ZEUS SYSTEM
Developed in partnership with Verily, the Zio® Watch and the ZEUS System combine to create a clinical grade watch to detect and characterize AFib and integrate with clinician’s workflow SAN FRANCISCO, July 22, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, […]
MemorialCare Long Beach Medical Center is Nationally Recognized with American Heart Association/American Stroke Association…
MemorialCare Long Beach Medical Center is Nationally Recognized with American Heart Association/American Stroke Association’s Gold Plus Awards for Heart Failure, Stroke Care, and Diabetes LONG BEACH, Calif., July 21, 2022 /PRNewswire/ — MemorialCare Long Beach Medical Center has received the American Heart Association’s Get With The Guidelines® – Heart Failure Gold Plus Quality Achievement […]
Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results
CARLSBAD, Calif., July 21, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that David Roman has been appointed President and Chief Executive Officer, and member of the Board […]
RapidAI Receives FDA Clearance for Rapid Hyperdensity
The new solution allows for quick identification of hyperdense volumes to improve hemorrhage management SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA clearance for Rapid Hyperdensity, the newest addition to the RapidAI platform. The tool empowers […]
SANUWAVE® Business Update – June 2022
Estimated June Revenue Increase of 75% Year Over Year Sales Funnel Increases 9% and System Trials Increases 5% Month Over Month SUWANEE, GA, July 21, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — On July 14, 2022, SANUWAVE Health, Inc. (OTC: PINK: SNWV), a leading provider of next-generation wound care products, provided an […]
BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute
Led by Dhanunjaya DJ Lakkireddy, MD., the study will investigate expanded applications for the signals acquired by BioSig’s PURE EP(T.M.) System Westport, CT, July 21, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal […]
dal-GenE Phase 3 Cardiovascular Precision Medicine Outcomes Trial Results Published in European Heart Journal
Trial was negatively impacted by the COVID-19 pandemic and did not meet the primary endpoint. However, the results validate the interaction between dalcetrapib treatment and AA genotype at variant rs1967309 in the ADCY9 gene. LONDON and MONTREAL, July 21, 2022 (GLOBE NEWSWIRE) — DalCor Pharmaceuticals announced the results of the […]
Recent
Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
Advanced Bifurcation Systems Inc. Acquires Svelte Medical Systems, Inc.
Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026
Popular
- No commented posts yet